cbdMD Announces Company’s CEO Joins the Board of Directors 
ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.
RAMSEY, N.J. and BOCA RATON, Fla. and GOOSE CREEK, S.C., April 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:...
Intercept to Announce First Quarter 2021 Financial Results on May 6, 2021
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
Zosano Pharma Confirms Plan to Move Forward with Pharmacokinetic Study Following Protocol Review by FDA
– Company Establishes Agreement with Worldwide Clinical Trials to Conduct PK Study – – Anticipates initiating PK Study in June and Completion...
Fountain Therapeutics Appoints William L. Greene, M.D. Chief Executive Officer
SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Fountain Therapeutics, a biopharmaceutical company building a pipeline of therapeutics...
Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer
CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease
One-Time Gene Therapy to be Evaluated in Patients with Early Huntington’s Disease Initiation of VYTAL Phase 1/2 Clinical Trial at...
Daré Bioscience Announces the Presentation of DARE-BVFREE Phase 3 Clinical Trial Results at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data...
Genetic Technologies’ COVID-19 Risk Test Approved for Commercial Release
MELBOURNE, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics...
Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy
HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types...
Rubius Therapeutics to Announce First Quarter 2021 Financial Results
CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering...
Alignment Healthcare to Announce First Quarter 2021 Financial Results and Host Conference Call Monday, May 17, 2021
ORANGE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a mission-based,...
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record...
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder
Shorter Protocol Further Expands Access to CareCRESSKILL, N.J. and JERUSALEM, April 26, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &...
Nephros Announces First Quarter 2021 Financial Results Conference Call
SOUTH ORANGE, NJ, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology...
TG Therapeutics to Participate in the B. Riley Securities Neuroscience Conference
Fireside chat scheduled for Wednesday, April 28, 2021 at 9:00 AM ETNEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- TG...
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™
This yield level demonstrates commercial viability; supports advancing to large-scale productionVANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed...
Mydecine to Report Full Year 2020 Financial Results on May 3, 2021
DENVER, April 26, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’),...
ContraFect Invited to Participate in the Cystic Fibrosis Target Product Profile Virtual Symposium
YONKERS, N.Y., April 26, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...
Auxly Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021
TORONTO, April 26, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) ("Auxly" or the "Company"),...